Europe and Middle East & Africa Respiratory Panel Testing Market to Exceed Valuation of US$ 3.1 Bn by 2031: Transparency Market Research

Europe and Middle East & Africa Respiratory Panel Testing Market: Introduction

According to the report, the respiratory panel testing market in EMEA was valued over US$ 1.6 Bn in 2020 and is projected to expand at a CAGR of 5.1% from 2021 to 2031. Respiratory panel testing is a diagnostic panel used for the detection of virus, bacteria, fungi, parasites, and other pathogens. Pathogens cause various respiratory diseases, which are life threatening. This increases the need of accurate identification of the pathogens. Respiratory tract infections are the most common diseases spreading across regions. Most respiratory panels available in the market offer high performance and have clinical significance in rapid pathogen detection.

Key Strategies by Leading Players to Boost Europe and Middle East & Africa Respiratory Panel Testing Market

In September 2021, Roche signed a definitive share purchase agreement with TIB Molbiol Group to expand PCR-test portfolio against infectious diseases. The acquisition will enhance Roche's portfolio of molecular diagnostic solutions with a wide range of assays for infectious diseases, such as the identification of SARS-CoV-2 variants.

In June 2021, bioMerieux SA launched EPISEQ SARS-COV-2, a genomic software solution to support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants.

In June 2020, DiaSorin Molecular received CE mark for its Simplexa Flu A/B & RSV Direct Gen II assay for influenza and respiratory syncytial virus (RSV). In April 2021, altona Diagnostics GmbH launched the AltoStar HIV RT-PCR Kit 1.5, an in vitro diagnostic test, based on real-time RT-PCR technology, for the detection and quantification of human immunodeficiency virus type 1 (HIV-1) specific RNA (groups M, N and O) in human EDTA plasma.

In May 2021, CerTest Biotec S.L. entered into partnership with BD to detect COVID-19 in saliva. Under the terms of the partnership, VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit, which is used in the BD MAX Molecular Diagnostic System, will be sold through BD’s distribution network.

Viruses Segment to Lead Europe and Middle East & Africa Respiratory Panel Testing Market

In terms of specimen type, the respiratory panel testing market in EMEA has been bifurcated into viruses and bacteria. The viruses segment held major market share in 2020, owing to the availability of the respiratory panel testing for diverse range of viruses. Onset of coronavirus infections across Europe and Middle East & Africa is anticipated to increase diagnosis testing. Surge in incidence of viral infections across the regions is expected to boost the growth of the segment in the next few years.

According to WHO, countries with the highest death toll due to coronavirus are Russia, the U.K., Italy, and France, each having reported over 100,000 deaths in 2020. These statistics are likely to boost panel testing for respiratory diseases across the region.

Syndromic Full Multiplex Panel Segment to Dominate Europe and Middle East & Africa Respiratory Panel Testing Market

Based on panel type, the respiratory panel testing market in EMEA has been classified into syndromic full multiplex panel and low plex panel. The syndromic full multiplex panel segment accounted for major market share in 2020, owing to its preference over low plex panel. Syndromic full multiplex panel uses one test to target multiple pathogens for faster detection. This panel has enabled laboratories to rapidly identify virus, bacteria, parasites, fungi, and other organism at higher specificity and sensitivity.

Hospitals to be Key End-user

In terms of end-user, the respiratory panel testing market in EMEA has been divided into hospital point-of-care testing, ref laboratories, hospitals, and others. Hospitals complement and amplify the effectiveness of many other parts of the health system, providing continuous availability of services for acute and complex conditions. These concentrate scarce resources within well-planned referral networks to respond efficiently to population health needs. Increase in admission of patients suffering from respiratory diseases is likely to drive the segment during the forecast period.

Europe to Lead Europe and Middle East & Africa Respiratory Panel Testing Market

Europe dominated the respiratory panel testing market in EMEA in 2020, accounting for prominent share. Growing outbreak of coronavirus disease and other infectious diseases, well-established health care system, advanced health care facilities, growing molecular diagnostics market, and presence of key players offering respiratory panel tests are anticipated to boost the growth of the market in the region during the forecast period.

Germany is expected to be an attractive market from 2021 to 2031. The country is likely to account for significant share of the market in Europe during the forecast period. This is attributed to increase in cases of infections, rise in admission of patients in hospitals, surge in number of laboratories, and technological advancements leading to the availability of diagnostic kits for respiratory disease testing.

Competition Landscape

The respiratory panel testing market in EMEA is fragmented due to presence of large number of leading players. Key players operating in the market include F. Hoffmann-La Roche Ltd., bioMerieux SA, Medline Industries, Inc., Becton, Dickinson & Company, altona Diagnostics GmbH, CerTest Biotec S.L., Anatolia Geneworks, Seegene, Inc., DiaSorin S.p.A. (Luminex), QIAGEN, and Biocartis.

Europe and Middle East & Africa Respiratory Panel Testing Market: Segmentation

  • Europe and Middle East & Africa Respiratory Panel Testing Market, by Specimen Type
    • Viruses
      • Adenovirus
      • Severe Acute Respiratory Syndrome Coronavirus 2
      • RSV
      • Human Metapneumovirus
      • Rhinovirus/Enterovirus
      • Parainfluenza Virus
      • Flu A
      • Coronavirus
      • Flu B
      • H1N12009
      • Others
    • Bacteria
      • Mycoplasma Pneumoniae
      • Chlamydophila Pneumonia
      • Bordetella Pertussis
      • Bordetella Parapertussis
  • Europe and Middle East & Africa Respiratory Panel Testing Market, by Panel Type
    • Syndromic Full Multiplex Panel
    • Low Plex Panel
  • Europe and Middle East & Africa Respiratory Panel Testing Market, by End-user
    • Hospital Point-of-Care testing
    • Ref Laboratories
    • Hospitals
    • Others
  • Europe and Middle East & Africa Respiratory Panel Testing Market, by Country/Sub-region
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Finland
    • Austria
    • Switzerland
    • Benelux
    • Norway
    • Poland
    • Rest of Europe

About Us

Transparency Market Research is a global market intelligence company, providing EMEA business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

7 of 10 large enterprizes view our Report to take the right decision.

View Report